Literature DB >> 319730

Effects of dimethyl sulfoxide on ocular inflammation.

C Hanna, F T Fraunfelder, S M Meyer.   

Abstract

The anti-inflammatory properties of topical ocular dimethyl sulfoxide (DMSO) were investigated using a standard experimental model of an acute inflammatory ocular inflammation. Ninety percent and 100% DMSO aggravated the inflammatory response, 50% to 70% DMSO had similar responses as the control eye; however, 30% DMSO had definite anti-inflammatory properties. Dexamethasone 0.1% was superior to 30% DMSO as an anti-inflammatory agent. From this study it is evident that high concentrations of DMSO are irritating to the inflammatory ocular model used while lower concentrations have anti-inflammatory properties. The two side effects of skin irritation at the site of application and breath odor may be the subjective influence that leads certain patients to report a beneficial effect of DMSO treatment in ocular inflammation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 319730

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  4 in total

1.  In vitro-controlled release delivery system for hydrogen sulfide donor.

Authors:  Hatim Ali; Catherine Opere; Somnath Singh
Journal:  AAPS PharmSciTech       Date:  2014-04-24       Impact factor: 3.246

2.  Dimethyl sulphoxide dose-response on rat retinal function.

Authors:  Tina I Tsai; Bang V Bui; Algis J Vingrys
Journal:  Doc Ophthalmol       Date:  2009-09-11       Impact factor: 2.379

3.  Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature.

Authors:  Jesse S Pelletier; Kevin P Stewart; Kara Capriotti; Joseph A Capriotti
Journal:  Ophthalmol Ther       Date:  2015-11-02

4.  Inflammation in Dry Eye Syndrome: Identification and Targeting of Oxylipin-Mediated Mechanisms.

Authors:  Dmitry V Chistyakov; Olga S Gancharova; Viktoriia E Baksheeva; Veronika V Tiulina; Sergei V Goriainov; Nadezhda V Azbukina; Marina S Tsarkova; Andrey A Zamyatnin; Pavel P Philippov; Marina G Sergeeva; Ivan I Senin; Evgeni Yu Zernii
Journal:  Biomedicines       Date:  2020-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.